All In Biotech

Free tool

FAERS Monitor: Eryc

The FDA Adverse Event Reporting System collects reports from patients, clinicians and manufacturers. Counts are unverified reports, not rates: they rise with how widely a drug is used, how long it has been sold and media attention, a report can name several drugs, and a report does not show the drug caused the event.

Last checked: Nov 20, 2026FDA FAERS (openFDA) last updated: Oct 28, 2026Methods & limitations

Reports naming NDA 050536 or its brand name (Eryc, Erythromycin). Reports on generic versions are filed under their own applications.

Reports

18,337

Serious

11,285

62% of reports

Hospitalization

4,843

Death reported

1,661

Any cause; not necessarily from the drug

Most reported reactions

MedDRA preferred terms.

  • drug hypersensitivity4,099
  • nausea1,272
  • vomiting1,107
  • drug ineffective1,100
  • diarrhoea1,076
  • fatigue1,058
  • dyspnoea1,050
  • rash1,018
  • off label use953
  • headache883
  • dizziness791
  • pain787
  • pyrexia712
  • malaise706
  • hypersensitivity684

Reports by year received

View as table
YearReports
2004202
2005231
2006225
2007209
2008290
2009424
2010485
2011443
2012625
2013574
2014579
2015664
20161,201
20171,085
20181,379
20191,759
20201,294
20211,299
20221,109
20231,260
20241,272
20251,079
2026648

Disproportionality screen

Proportional reporting ratio (PRR): how much more often each reaction appears in this drug's reports than in the other 21,035,822 FAERS reports. Flagged when PRR is at least 2, chi-squared at least 4 and there are 3 or more reports (Evans criteria). A screening statistic only.

ReactionReportsPRR95% CI lowerChi-squared
drug hypersensitivitySignal4,09924.824.192,464
hypersensitivitySignal6844.23.91,698
vomitingSignal1,1072.72.61,212
rashSignal1,0182.72.51,093
pyrexiaSignal7122.42.2567
dyspnoeaSignal1,0502.12.0644
diarrhoea1,0761.91.8482
malaise7061.81.7279
nausea1,2721.81.7510
dizziness7911.81.7298
headache8831.61.5213
fatigue1,0581.61.5220
pain7871.51.4121
off label use9531.21.249
drug ineffective1,1001.00.92

A high PRR for a reaction that is also the condition being treated (for example "disease progression" for a cancer drug) is expected and is not a safety signal.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.